April 11, 2019
Sanofi’s atopic dermatitis and asthma treatment Dupixent (dupilumab) will be available for self-injection as the Central Social Insurance Medical Council, a key reimbursement policy panel better known as Chuikyo, endorsed on April 10 its addition to a list of products...read more